FIRST-ROP算法在三级NICU三十年中等风险队列中的验证
该回顾性诊断对比研究纳入胎龄≥27周且出生体重≥800g的8564名筛查婴儿中的3641名中等风险婴儿,验证将首次ROP筛查推迟至矫正胎龄34周的FIRST-ROP算法。结果显示34周前无婴儿需要治疗,该策略未漏诊需治疗ROP,且显著减少检查次数。
要点
- 中等风险婴儿中,首次ROP诊断中位矫正胎龄为35.1周。
- 34周前无婴儿需要治疗,FIRST-ROP策略未漏诊需治疗ROP。
- 从34周开始筛查可显著减少检查次数,估计每患者就诊减少17%。
核心结论
- 在中等风险婴儿队列中,将首次ROP筛查推迟至矫正胎龄34周的FIRST-ROP算法被验证为安全,未漏诊需治疗ROP。
研究设计与样本
- 回顾性诊断对比研究,纳入胎龄≥27周且出生体重≥800g的婴儿,共3641名符合标准。
主要发现
- 8564名筛查婴儿中3641名(36%)符合纳入标准,其中604名(17%)发生ROP。
- 首次ROP诊断中位矫正胎龄35.1周(IQR 34.0-36.6周;范围31.3-51.4周)。
- 从34周矫正胎龄开始筛查较标准筛查显著减少检查次数(P < .001),估计每患者就诊减少17%。
- FIRST-ROP策略下无漏诊需治疗ROP病例(95% CI 99.3%-100%)。
关键数值与推荐
- FIRST-ROP算法将首次ROP筛查推迟至矫正胎龄34周。
- 需治疗ROP漏诊率为0(95% CI 99.3%-100%)。
临床怎么用
- 对胎龄≥27周且出生体重≥800g的中等风险婴儿,可考虑将首次ROP筛查推迟至矫正胎龄34周。
- 该策略可减少筛查负担,同时维持对需治疗ROP的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To validate the FIRST-ROP algorithm in a medium-risk cohort of infants undergoing screening for retinopathy of prematurity (ROP). DESIGN: Retrospective diagnostic comparison. METHODS: Infants who did not meet criteria for microprematurity or nanoprematurity (gestational age ≥ 27 weeks and birth weight ≥ 800 g) were included. Outcomes assessed included rates of ROP diagnosis and treatment-warranted ROP (TW-ROP), as well as postmenstrual age (PMA) at first diagnosis and initiation of treatment. Paired binary detection outcomes between traditional ROP screening strategies and the FIRST-ROP algorithm, which defers screening until 34 weeks PMA, were compared using the McNemar test. RESULTS: Among 8564 infants screened, 3641 (36%) met inclusion criteria, of whom 604 (17%) developed ROP. Median PMA at first ROP diagnosis was 35.1 weeks (interquartile range [IQR], 34.0-36.6 weeks; range, 31.3-51.4 weeks). Median PMA at stage 3 diagnosis was 35.6 weeks (IQR, 34.0-37.0 weeks; range, 32.3-47.6 weeks). Median PMA at first treatment was 40.0 weeks (IQR, 37.1-41.4 weeks; range, 34.3-44.4 weeks). Fifteen infants (2%) required treatment, of whom 10 (67%) had type 1 ROP. Initiating screening at 34 weeks PMA significantly reduced examinations compared with standard screening (P < .001), corresponding to an estimated 17% fewer visits per patient. No cases of TW-ROP would have been missed under the FIRST-ROP strategy (95% CI, 99.3%-100%). CONCLUSIONS: Over 3 decades, no infants in this medium-risk cohort required treatment before 34 weeks PMA. These findings validate the FIRST-ROP algorithm and support safe deferral of the initial ROP examination to 34 weeks PMA, reducing screening burden while maintaining sensitivity for TW-ROP.
引用
- Malek DA, Altamirano F, Chaaya C, et al. Validation of the "FIRST-ROP" Algorithm at a Neonatal Intensive Care Unit Tertiary Center over Three Decades. Am J Ophthalmol. 2026. PMID: 42002018. doi:10.1016/j.ajo.2026.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。